Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palifermin for Oral Mucositis in Head and Neck Cancer
NCT00540332Phase 2Withdrawn
- Sponsor
- Sobi
- Start
- Oct 2007
- Primary completion
- Sep 2008
- Modality
- Cytokines & Interferons
01
Overview
A Phase 2 trial of palifermin in oral mucositis (OM), sponsored by Sobi. Planned start Oct 2007; status: withdrawn.
02
Drugs
palifermin
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT00540332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00540332.